Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/30252
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLuk, Ian Y-
dc.contributor.authorJenkins, Laura J-
dc.contributor.authorSchoffer, Kael L-
dc.contributor.authorNg, Irvin-
dc.contributor.authorTse, Janson W T-
dc.contributor.authorMouradov, Dmitri-
dc.contributor.authorKaczmarczyk, Stanislaw-
dc.contributor.authorNightingale, Rebecca-
dc.contributor.authorBurrows, Allan D-
dc.contributor.authorAnderson, Robin L-
dc.contributor.authorArango, Diego-
dc.contributor.authorDopeso, Higinio-
dc.contributor.authorCroft, Larry-
dc.contributor.authorRichardson, Mark F-
dc.contributor.authorSieber, Oliver M-
dc.contributor.authorLiao, Yang-
dc.contributor.authorMooi, Jennifer K-
dc.contributor.authorVukelic, Natalia-
dc.contributor.authorReehorst, Camilla M-
dc.contributor.authorAfshar-Sterle, Shoukat-
dc.contributor.authorWhitehall, Vicki L J-
dc.contributor.authorFennell, Lochlan-
dc.contributor.authorAbud, Helen E-
dc.contributor.authorTebbutt, Niall C-
dc.contributor.authorPhillips, Wayne A-
dc.contributor.authorWilliams, David S-
dc.contributor.authorShi, Wei-
dc.contributor.authorMielke, Lisa A-
dc.contributor.authorErnst, Matthias-
dc.contributor.authorDhillon, Amardeep S-
dc.contributor.authorClemons, Nicholas J-
dc.contributor.authorMariadason, John M-
dc.date2022-
dc.date.accessioned2022-06-23T00:31:32Z-
dc.date.available2022-06-23T00:31:32Z-
dc.date.issued2022-05-23-
dc.identifier.citationCell Death and Differentiation 2022; 29(11)en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/30252-
dc.description.abstractColorectal cancers (CRCs) often display histological features indicative of aberrant differentiation but the molecular underpinnings of this trait and whether it directly drives disease progression is unclear. Here, we identify co-ordinate epigenetic inactivation of two epithelial-specific transcription factors, EHF and CDX1, as a mechanism driving differentiation loss in CRCs. Re-expression of EHF and CDX1 in poorly-differentiated CRC cells induced extensive chromatin remodelling, transcriptional re-programming, and differentiation along the enterocytic lineage, leading to reduced growth and metastasis. Strikingly, EHF and CDX1 were also able to reprogramme non-colonic epithelial cells to express colonic differentiation markers. By contrast, inactivation of EHF and CDX1 in well-differentiated CRC cells triggered tumour de-differentiation. Mechanistically, we demonstrate that EHF physically interacts with CDX1 via its PNT domain, and that these transcription factors co-operatively drive transcription of the colonic differentiation marker, VIL1. Compound genetic deletion of Ehf and Cdx1 in the mouse colon disrupted normal colonic differentiation and significantly enhanced colorectal tumour progression. These findings thus reveal a novel mechanism driving epithelial de-differentiation and tumour progression in CRC.en
dc.language.isoeng-
dc.titleEpithelial de-differentiation triggered by co-ordinate epigenetic inactivation of the EHF and CDX1 transcription factors drives colorectal cancer progression.en
dc.typeJournal Articleen
dc.identifier.journaltitleCell Death and Differentiationen
dc.identifier.affiliationOlivia Newton-John Cancer Research Instituteen
dc.identifier.affiliationDepartment of Anatomical Pathology, Austin Health, Heidelberg, VIC, Australiaen
dc.identifier.affiliationLa Trobe University School of Cancer Medicine, Melbourne, VIC, Australiaen
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Melbourne, VIC, Australiaen
dc.identifier.affiliationThe University of Queensland, St Lucia, QLD, Australiaen
dc.identifier.affiliationDevelopment and Stem Cells Program and the Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Melbourne, VIC, Australiaen
dc.identifier.affiliationDepartment of Clinical Pathology, University of Melbourne, Parkville, VIC, Australiaen
dc.identifier.affiliationSchool of Computing and Information Systems, University of Melbourne, Parkville, VIC, Australiaen
dc.identifier.affiliationThe Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, VIC, Australiaen
dc.identifier.affiliationPeter MacCallum Cancer Centre, Melbourne, VIC, Australiaen
dc.identifier.affiliationConjoint Internal Medicine Laboratory, Pathology Queensland, Brisbane, QLD, Australiaen
dc.identifier.affiliationQIMR Berghofer Medical Research Institute, Herston, QLD, Australiaen
dc.identifier.affiliationDepartment of Surgery, The University of Melbourne, Parkville, VIC, Australiaen
dc.identifier.affiliationDepartment of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australiaen
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Melbourne, VIC, Australiaen
dc.identifier.affiliationPersonalised Oncology Division, The Walter and Eliza Hall Institute of Medial Research, Parkville, VIC, Australiaen
dc.identifier.affiliationDepartment of Medical Biology, The University of Melbourne, Parkville, VIC, Australiaen
dc.identifier.affiliationThe Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australiaen
dc.identifier.affiliationSchool of Life and Environmental Sciences, Deakin University, Geelong, VIC, Australiaen
dc.identifier.affiliationGroup of Biomedical Research in Digestive Tract Tumors, CIBBIM-Nanomedicine, Vall d'Hebron University Hospital Research Institute (VHIR), Barcelona, Spainen
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/35606410/en
dc.identifier.doi10.1038/s41418-022-01016-wen
dc.type.contentTexten
dc.identifier.orcid0000-0003-0595-1414en
dc.identifier.orcid0000-0003-0060-1861en
dc.identifier.orcid0000-0003-3214-3527en
dc.identifier.orcid0000-0003-3792-4023en
dc.identifier.orcid0000-0002-7961-638Xen
dc.identifier.orcid0000-0002-6399-1177en
dc.identifier.orcid0000-0001-9283-9978en
dc.identifier.orcid0000-0001-9123-7684en
dc.identifier.orcid0000-0001-9218-8669en
dc.identifier.orcid0000-0002-5683-9935en
dc.identifier.orcid0000-0002-1357-4666en
dc.identifier.orcid0000-0002-6841-7422en
dc.identifier.orcid0000-0002-4188-6149en
dc.identifier.orcid0000-0002-8039-3582en
dc.identifier.orcid0000-0003-2613-5168en
dc.identifier.orcid0000-0003-4616-9605en
dc.identifier.orcid0000-0002-9522-9320en
dc.identifier.orcid0000-0002-6065-663Xen
dc.identifier.pubmedid35606410-
local.name.researcherAfshar-Sterle, Shoukat
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.languageiso639-1en-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
crisitem.author.deptMedical Oncology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

60
checked on Dec 30, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.